Table 2.
Variable | Netherlands | Germany | France | p-value | Total study population |
---|---|---|---|---|---|
n = 420 | n = 165 | n = 131 | n = 965 | ||
Symptom onset to balloon time (min) | 165 (20–318) | 270 (120–615) | 360 (180–660) | <0.0001 | 210 (120–480) |
TIMI flow culprit vessel pre-procedure | <0.0001 | – | |||
0 | 229 (55 %) | 92 (56 %) | 92 (56 %) | – | 551 (57 %) |
1 | 54 (13 %) | 33 (20 %) | 33 (20 %) | – | 127 (13 %) |
2 | 78 (19 %) | 27 (16 %) | 27 (16 %) | – | 162 (17 %) |
3 | 54 (13 %) | 13 (8 %) | 13 (7.9 %) | – | 120 (13 %) |
TIMI flow culprit vessel post-procedure | 0.500 | – | |||
0 | 4 (1.0 %) | 4 (2.4 %) | 0 | – | 10 (1 %) |
1 | 1 (0.2 %) | 1 (0.6 %) | 1 (0.8 %) | – | 4 (0.40 %) |
2 | 16 (3.8 %) | 8 (4.8 %) | 5 (3.8 %) | – | 39 (4 %) |
3 | 397 (95 %) | 152 (92 %) | 125 (95 %) | – | 910 (95 %) |
TIMI Thrombolysis In Myocardial Infarction